Birx Deborah Insider Trades

Insider Trading History

Track insider trading activity for Birx Deborah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $778k 198,417 shares
Last Trade
Jul 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$59.8k 14,041 shares
$4.26
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $833k 212,458 shares
Last Trade
Mar 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.8k 4,919 shares
$10.54
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $1.65M 421,226 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.89M 421,226 shares
$11.61
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $852k 217,377 shares
Last Trade
Jul 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$31k 13,637 shares
$2.27
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $906k 231,014 shares
Last Trade
Mar 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.8k 6,061 shares
$1.95
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $941k 240,000 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 240,000 shares
$2.04
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $929k 237,075 shares
Last Trade
Jul 10, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.4k 22,925 shares
$2.68
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $1.02M 260,000 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$811k 240,000 shares
$3.38
$3.92
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Executive Officer
Holding Value $784k 200,000 shares
Last Trade
Dec 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 200,000 shares
$2.39
$3.92
Innoviva
Innoviva INVA
Director
Holding Value $1.28M 58,984 shares
Last Trade
May 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 10,000 shares
$13.64
$21.74
Innoviva
Innoviva INVA
Director
Holding Value $924k 42,489 shares
Last Trade
Apr 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 12,647 shares
$17.79
$21.74
Innoviva
Innoviva INVA
Director
Holding Value $649k 29,842 shares
Last Trade
May 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 17,482 shares
$12.87
$21.74
Innoviva
Innoviva INVA
Director
Holding Value $269k 12,360 shares
Last Trade
Mar 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.6k 1,612 shares
$12.13
$21.74
Innoviva
Innoviva INVA
Director
Holding Value $234k 10,748 shares
Last Trade
Mar 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 10,748 shares
$12.35
$21.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up